Blog

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Blog

Tom Powles and Giorgio Bogani Discuss the Recently Published Study on Advanced or Recurrent Endometrical Cancer

Photo collage of Tom Powles and Giorgio Bogani taken from their LinkedIn

Jun 15, 2024, 07:36

Tom Powles and Giorgio Bogani Discuss the Recently Published Study on Advanced or Recurrent Endometrical Cancer

The European Society for Medical Oncology (ESMO) posted on LinkedIn:

“Latest podcast Annals of Oncology Editor-in-Chief Tom Powles talks to Giorgio Bogani. They discuss the recently published study considering recent phase III trials that investigated the role of Immunotherapy in the first-line setting for advanced or recurrent Endometrical Cancer.”

Read further.
Source: The European Society for Medical Oncology (ESMO)/LinkedIn

advanced cancer Annals of Oncology cancer Cancer research cancer studies Endometrial cancer ESMO first-line treatment Giorgio Bogani immunotherapy OncoDaily Oncology oncology podcast phase III trials recurrent cancer Tom Powles

Jun 26, 2024, 12:40

EGFR co-inhibition in KRAS

Jun 26, 2024, 12:33

St. Jude Children’s Research Hospital’s educational event on Pneumocystis Jirovecii in Pediatric Cancer - SIOP

Jun 26, 2024, 12:21

Karen Knudsen: Kicking off our American Cancer Society Cancer Action Network advocacy event

Jun 26, 2024, 12:19

Brilliant keynote lecture on KRAS inhibitors by Dr. Ryan Corcoran at ESMOGI24

Jun 26, 2024, 12:09

Myeloma Paper of the Day, June 26th, suggested by Robert Orlowski

Jun 26, 2024, 12:05

Piotr Wysocki: Osimertinib after radiochemotherapy improves PFS in EGFR-mutated NSCLC patients – but is it really what they need?

Jun 26, 2024, 11:45

Sachin Jain: What are your thoughts on how we came to devalue expertise as a society?

Jun 26, 2024, 11:16

Access to medicine is a human right - The Max Foundation

Jun 26, 2024, 11:01

Cancer Research Institute's virtual Patient Immunotherapy Summit

Jun 26, 2024, 10:24

Chandler Park: Which patients would you not give EV-Pembro for 1st line metastatic bladder cancer?

Jun 26, 2024, 09:54

Miguel Bronchud: How often is post-recurrence treatment reported in adjuvant and neoadjuvant oncology randomized clinical trials?

Jun 26, 2024, 09:38

Katia Roque: Two poster presentations about cervical cancer and GTN at ESMOgynae2024